Evaluation of In vitro Antioxidant and In vivo Antihyperlipidemic Activities of Methanol Extract of Aerial Part of Crassocephalum crepidioides (Asteraceae) Benth S Moore
Abstract
Purpose: To evaluate the antioxidant and antihyperlipidemic activities of the methanol extract of aerial part of Crassocephalum crepidioides (Asteraceae) Benth. S. Moore.
Methods: The methanol extract of Crassocephalum crepidioides was prepared by organic solvent extraction (Maceration) and assessed for in vitro antioxidant activity using various methods, namely, 2,2 diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, total phenol and flavonoid content and reducing capacity. The extract was also evaluated for antihyperlipidemic activity in high-fat diet and triton WR-100 (iso-octyl polyoxyethylene phenol)-induced hyperlipidemic albino rats by evaluating serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), triglycerides (TG), very low density lipoprotein cholesterol (VLDL-c), low-density lipoprotein cholesterol (LDL-c) level and atherogenic index (AI).
Results: The plant extract showed significant antioxidant activity in a dose-dependent manner. In highfat diet hyperlipedemic rats, the extract significantly reduced (p < 0.01 or 0.001) serum TC, TG, LDL-c and VLDL-c levels, but significantly increased (p < 0.05) serum HDL c level. In triton-induced hyperlipidemic rats, the extract significantly reduced (p < 0.05, p < 0.01, p < 0.001) serum TC, TG, LDLc, VLDL-c levels but significantly increased (p < 0.05) serum HDL-c level. The extract showed significant reduction (p < 0.01) in AI at 300 mg /kg/day dose in both high fat-induced (1.70 ± 0.25) and tritoninduced (1.5 ± 0.17) hyperlipidemic albino rats.
Conclusion: Based on these findings, the extract of Crassocephalum crepidioides aids in lowering hyperlipidemia in rats. This is probably due to its antioxidant activity.
Keywords: Antioxidant, Antihyperlipidemic, Crassocephalum crepidioides, Triton WR-100, Atherogenic index
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
